Literature DB >> 357181

Pleural reactions to environmental agents.

H A Anderson, I J Selikoff.   

Abstract

In the past, pleural disease has been uncommon, generally limited to infection derived from underlying pulmonary involvement or the result of local neoplastic invasion or hematogenous metastases. The deep, protected location of the lung's mesothelial surface provides insufficient defense against environmentally derived very fine biologically active inorganic particles, and a new set of abnormalities--pleural plaques, fibrosis, unique calcification, malignancy (mesothelioma), benign asbestotic effusion--have introduced problems of pathogenesis, diagnosis, management, and therapy. These changes are becoming frequent among individuals who were exposed to asbestos more than 20 years ago. Occupational exposure (direct and indirect), and in some cases environmental exposure (household contacts of asbestos-exposed workers and factory neighborhood residents), have been associated with higher prevalence of radiographically evident pleural abnormalities. What effects such changes will have on morbidity and mortality rates is incompletely understood.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 357181

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  5 in total

1.  Asbestos-related lung disease.

Authors: 
Journal:  West J Med       Date:  1979-09

2.  Benign asbestosis: words and thoughts.

Authors:  T Beritić
Journal:  Br J Ind Med       Date:  1988-07

3.  Radiographic changes in chrysotile mine and mill ex-workers in Corsica. A survey 14 years after cessation of exposure.

Authors:  J R Viallat; C Boutin
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Development of radiological and clinical evidence of parenchymal fibrosis in men with non-malignant asbestos-related pleural lesions.

Authors:  G H McMillan; C E Rossiter
Journal:  Br J Ind Med       Date:  1982-02

5.  Respiratory function changes after asbestos pleurisy.

Authors:  P H Wright; A Hanson; L Kreel; L H Capel
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.